Chetan Rathi
Simulation Technologies (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Antibiotics Pharmacokinetics and Efficacy, Cardiac Arrhythmias and Treatments, Cancer therapeutics and mechanisms, Cardiac pacing and defibrillation studies
Most-Cited Works
- → Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux(2014)192 cited
- → The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients(2020)77 cited
- → Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors(2023)67 cited
- → Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality(2017)60 cited
- → Clinical pharmacology of bispecific antibody constructs(2015)43 cited
- → Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India(2020)34 cited
- → Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method(2016)31 cited
- → Translational PK/PD of anti-infective therapeutics(2016)29 cited
- → Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma(2021)27 cited
- → Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis(2021)24 cited